NCT01545739View on ClinicalTrials.gov

Evia/Entovis HF-T Master Study

CompletedOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Indication for Cardiac Resynchronization Therapy (CRT)
Interventions
DEVICE

Evia/Entovis HF-T pacemaker for CRT therapy

Implantation of CRT pacemaker and standard follow-ups at pre-hospital discharge, and after 1, 3 and 6 months

Trial Locations (1)

1122

Semmelweis University, Budapest

All Listed Sponsors
lead

Biotronik SE & Co. KG

INDUSTRY

NCT01545739 - Evia/Entovis HF-T Master Study | Biotech Hunter | Biotech Hunter